Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3′ group chirality
- 1 February 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (4) , 567-570
- https://doi.org/10.1016/s0960-894x(00)00719-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (Stromelysin-1)Bioorganic & Medicinal Chemistry Letters, 2001
- Epidermal Expression of Collagenase Delays Wound-Healing in Transgenic MiceJournal of Investigative Dermatology, 1998
- Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl DipeptidesJournal of Medicinal Chemistry, 1997
- Structural Insights into the Catalytic Domains of Human Matrix Metalloprotease-2 and Human Matrix Metalloprotease-9: Implications for Substrate SpecificitiesJournal of Molecular Modeling, 1997
- Patent Update Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic: Recent advances in the field of matrix metalloproteinase inhibitorsExpert Opinion on Therapeutic Patents, 1996
- Gelatinase activity during wound healingBritish Journal of Dermatology, 1994
- Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.Journal of Clinical Investigation, 1993
- 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additiveJournal of the American Chemical Society, 1993
- A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinasesFEBS Letters, 1992
- Demonstration of tissue collagenase activity in vivo and its relationship to inflammation severity in human gingivaJournal of Periodontal Research, 1987